These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9569170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current estimates of the economic cost of obesity in the United States.
    Wolf AM, Colditz GA.
    Obes Res; 1998 Mar; 6(2):97-106. PubMed ID: 9545015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term cost-effectiveness of weight management in primary care.
    Trueman P, Haynes SM, Felicity Lyons G, Louise McCombie E, McQuigg MS, Mongia S, Noble PA, Quinn MF, Ross HM, Thompson F, Broom JI, Laws RA, Reckless JP, Kumar S, Lean ME, Frost GS, Finer N, Haslam DW, Morrison D, Sloan B, Counterweight Project Team.
    Int J Clin Pract; 2010 May; 64(6):775-83. PubMed ID: 20353431
    [Abstract] [Full Text] [Related]

  • 5. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association.
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [Abstract] [Full Text] [Related]

  • 6. Lifetime health and economic consequences of obesity.
    Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G.
    Arch Intern Med; 1999 Oct 11; 159(18):2177-83. PubMed ID: 10527295
    [Abstract] [Full Text] [Related]

  • 7. The cost of obesity in Canada.
    Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH.
    CMAJ; 1999 Feb 23; 160(4):483-8. PubMed ID: 10081464
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of diabetes education.
    Urbanski P, Wolf A, Herman WH.
    J Am Diet Assoc; 2008 Apr 23; 108(4 Suppl 1):S6-11. PubMed ID: 18358259
    [Abstract] [Full Text] [Related]

  • 9. Social and economic effects of body weight in the United States.
    Wolf AM, Colditz GA.
    Am J Clin Nutr; 1996 Mar 23; 63(3 Suppl):466S-469S. PubMed ID: 8615344
    [Abstract] [Full Text] [Related]

  • 10. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
    Nuijten M, Marczewska A, Araujo Torres K, Rasouli B, Perugini M.
    J Med Econ; 2018 Sep 23; 21(9):835-844. PubMed ID: 29678127
    [Abstract] [Full Text] [Related]

  • 11. A health-economic comparison of diet and drug treatment in obese men with mild hypertension.
    Johannesson M, Fagerberg B.
    J Hypertens; 1992 Sep 23; 10(9):1063-70. PubMed ID: 1328366
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of obesity on rising medical spending.
    Thorpe KE, Florence CS, Howard DH, Joski P.
    Health Aff (Millwood); 2004 Sep 23; Suppl Web Exclusives():W4-480-6. PubMed ID: 15496437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of sibutramine in the treatment of obesity.
    Warren E, Brennan A, Akehurst R.
    Med Decis Making; 2004 Sep 23; 24(1):9-19. PubMed ID: 15005950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.